68 related articles for article (PubMed ID: 38438917)
21. Natural Anticancer Agents: Their Therapeutic Potential, Challenges,s and Promising Outcomes.
Tauro S; Dhokchawle B; Mohite P; Nahar D; Nadar S; Coutinho E
Curr Med Chem; 2023 May; ():. PubMed ID: 37138435
[TBL] [Abstract][Full Text] [Related]
22. Potential of Sulforaphane as a Natural Immune System Enhancer: A Review.
Mahn A; Castillo A
Molecules; 2021 Feb; 26(3):. PubMed ID: 33535560
[TBL] [Abstract][Full Text] [Related]
23. Sulforaphane Reduces Prostate Cancer Cell Growth and Proliferation In Vitro by Modulating the Cdk-Cyclin Axis and Expression of the CD44 Variants 4, 5, and 7.
Rutz J; Thaler S; Maxeiner S; Chun FK; Blaheta RA
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218199
[TBL] [Abstract][Full Text] [Related]
24. Taxane resistance in prostate cancer is mediated by decreased drug-target engagement.
Gjyrezi A; Xie F; Voznesensky O; Khanna P; Calagua C; Bai Y; Kung J; Wu J; Corey E; Montgomery B; Mace S; Gianolio DA; Bubley GJ; Balk SP; Giannakakou P; Bhatt RS
J Clin Invest; 2020 Jun; 130(6):3287-3298. PubMed ID: 32478682
[TBL] [Abstract][Full Text] [Related]
25. Current Cancer Epidemiology.
Mattiuzzi C; Lippi G
J Epidemiol Glob Health; 2019 Dec; 9(4):217-222. PubMed ID: 31854162
[TBL] [Abstract][Full Text] [Related]
26. Sulforaphane metabolites reduce resistance to paclitaxel via microtubule disruption.
Wang Y; Zhou Y; Zheng Z; Li J; Yan Y; Wu W
Cell Death Dis; 2018 Nov; 9(11):1134. PubMed ID: 30429459
[TBL] [Abstract][Full Text] [Related]
27. Broccoli Sprouts Delay Prostate Cancer Formation and Decrease Prostate Cancer Severity with a Concurrent Decrease in HDAC3 Protein Expression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) Mice.
Beaver LM; Lӧhr CV; Clarke JD; Glasser ST; Watson GW; Wong CP; Zhang Z; Williams DE; Dashwood RH; Shannon J; Thuillier P; Ho E
Curr Dev Nutr; 2018 Mar; 2(3):nzy002. PubMed ID: 30019025
[TBL] [Abstract][Full Text] [Related]
28. Rationalizing combination therapies.
Nat Med; 2017 Oct; 23(10):1113. PubMed ID: 28985211
[No Abstract] [Full Text] [Related]
29. Combination therapy in combating cancer.
Bayat Mokhtari R; Homayouni TS; Baluch N; Morgatskaya E; Kumar S; Das B; Yeger H
Oncotarget; 2017 Jun; 8(23):38022-38043. PubMed ID: 28410237
[TBL] [Abstract][Full Text] [Related]
30. Traditional Dietary Pattern Increases Risk of Prostate Cancer in Argentina: Results of a Multilevel Modeling and Bias Analysis from a Case-Control Study.
Niclis C; Román MD; Osella AR; Eynard AR; Díaz Mdel P
J Cancer Epidemiol; 2015; 2015():179562. PubMed ID: 26649040
[TBL] [Abstract][Full Text] [Related]
31. Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy.
Cipolla BG; Mandron E; Lefort JM; Coadou Y; Della Negra E; Corbel L; Le Scodan R; Azzouzi AR; Mottet N
Cancer Prev Res (Phila); 2015 Aug; 8(8):712-9. PubMed ID: 25968598
[TBL] [Abstract][Full Text] [Related]
32. How Taxol/paclitaxel kills cancer cells.
Weaver BA
Mol Biol Cell; 2014 Sep; 25(18):2677-81. PubMed ID: 25213191
[TBL] [Abstract][Full Text] [Related]
33. Dietary habits and prostate cancer prevention: a review of observational studies by focusing on South America.
Niclis C; Díaz Mdel P; Eynard AR; Román MD; La Vecchia C
Nutr Cancer; 2012; 64(1):23-33. PubMed ID: 22136636
[TBL] [Abstract][Full Text] [Related]
34. Bcl-x(L) retrotranslocates Bax from the mitochondria into the cytosol.
Edlich F; Banerjee S; Suzuki M; Cleland MM; Arnoult D; Wang C; Neutzner A; Tjandra N; Youle RJ
Cell; 2011 Apr; 145(1):104-16. PubMed ID: 21458670
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone.
Rivera E; Gomez H
Breast Cancer Res; 2010; 12 Suppl 2(Suppl 2):S2. PubMed ID: 21050423
[TBL] [Abstract][Full Text] [Related]
36. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.
Li Y; Zhang T; Korkaya H; Liu S; Lee HF; Newman B; Yu Y; Clouthier SG; Schwartz SJ; Wicha MS; Sun D
Clin Cancer Res; 2010 May; 16(9):2580-90. PubMed ID: 20388854
[TBL] [Abstract][Full Text] [Related]
37. Chemosensitization of prostate cancer by modulating Bcl-2 family proteins.
Karnak D; Xu L
Curr Drug Targets; 2010 Jun; 11(6):699-707. PubMed ID: 20298153
[TBL] [Abstract][Full Text] [Related]
38. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
Kraemer PC; Borre M
Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
[TBL] [Abstract][Full Text] [Related]
39. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.
Tse C; Shoemaker AR; Adickes J; Anderson MG; Chen J; Jin S; Johnson EF; Marsh KC; Mitten MJ; Nimmer P; Roberts L; Tahir SK; Xiao Y; Yang X; Zhang H; Fesik S; Rosenberg SH; Elmore SW
Cancer Res; 2008 May; 68(9):3421-8. PubMed ID: 18451170
[TBL] [Abstract][Full Text] [Related]
40. Discovery and development of sulforaphane as a cancer chemopreventive phytochemical.
Zhang Y; Tang L
Acta Pharmacol Sin; 2007 Sep; 28(9):1343-54. PubMed ID: 17723168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
